Want to see CMND full AI Analyst Report?
Total Valuation
Clearmind Medicine has a market cap or net worth of $3.11M. The enterprise value is -11.46M.
Market Cap$3.11M
Enterprise Value-11.46M
Share Statistics
Clearmind Medicine has 507,404 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding507,404
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Clearmind Medicine’s return on equity (ROE) is -3.23 and return on invested capital (ROIC) is -190.72%.
Return on Equity (ROE)-3.23
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-190.72%
Return on Capital Employed (ROCE)-4.75
Revenue Per Employee0.00
Profits Per Employee-964.16K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Clearmind Medicine is ―. Clearmind Medicine’s PEG ratio is 1.90.
PE Ratio―
PS Ratio0.00
PB Ratio339.13
Price to FCF-85.43
Price to Operating Cash Flow-0.16
PEG Ratio1.90
Income Statement
In the last 12 months, Clearmind Medicine had revenue of 0.00 and earned -3.86M in profits. Earnings per share was -24.24.
Revenue0.00
Gross Profit-49.36K
Operating Income-5.67M
Pretax Income-3.79M
Net Income-3.86M
EBITDA-3.72M
Earnings Per Share (EPS)-24.24
Cash Flow
In the last 12 months, operating cash flow was -7.54M and capital expenditures 4.00, giving a free cash flow of -7.54M billion.
Operating Cash Flow-7.54M
Free Cash Flow-7.54M
Free Cash Flow per Share-14.85
Dividends & Yields
Clearmind Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change-99.81%
50-Day Moving Average9.44
200-Day Moving Average55.49
Relative Strength Index (RSI)36.03
Average Volume (3m)43.16K
Important Dates
Clearmind Medicine upcoming earnings date is Mar 2, 2027, TBA (Confirmed).
Last Earnings DateSep 10, 2026
Next Earnings DateMar 2, 2027
Ex-Dividend Date―
Financial Position
Clearmind Medicine as a current ratio of 1.22, with Debt / Equity ratio of 13.89%
Current Ratio1.22
Quick Ratio1.22
Debt to Market Cap<0.01
Net Debt to EBITDA0.58
Interest Coverage Ratio-290.08
Taxes
In the past 12 months, Clearmind Medicine has paid 70.44K in taxes.
Income Tax70.44K
Effective Tax Rate-0.02
Enterprise Valuation
Clearmind Medicine EV to EBITDA ratio is -108.21, with an EV/FCF ratio of -84.97.
EV to Sales0.00
EV to EBITDA-108.21
EV to Free Cash Flow-84.97
EV to Operating Cash Flow-84.97
Balance Sheet
Clearmind Medicine has $15.93M in cash and marketable securities with $1.80M in debt, giving a net cash position of $14.13M billion.
Cash & Marketable Securities$15.93M
Total Debt$1.80M
Net Cash$14.13M
Net Cash Per Share$27.85
Tangible Book Value Per Share$6.89
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Clearmind Medicine is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast74.01%